STAT3 and neoplasm: This tumor-localized IL-6 is now thought to have effects on tumor cells, including activation of pro-oncogenic STAT3 signaling, enhancement of cell motility, reduction in cell-cell adhesion, promotion of epithelial to mesenchymal transformation (EMT), enhanced cell proliferation and thus, overall, enhanced metastatic spread [3,4,5,6,7].